Showing 611-620 of 1562 results for "".
Board Forum: Managing Overhead
https://modernaesthetics.com/topics/practice-development/board-forum-managing-overhead/35132/"Psleep": Psoriasis and Sleep
https://reachmd.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaImmune Imprinting and Vaccines: Rethinking the First Exposure to Influenza
https://reachmd.com/programs/medical-industry-feature/immune-imprinting-and-vaccines-rethinking-the-first-exposure-to-influenza/26669/Discover the potential role of immune imprinting in shaping how we approach influenza vaccination.Diabetes Highlights from ENDO 2013 - the 95th Annual Meeting of The Endocrine Society
https://reachmd.com/programs/conference-coverage/diabetes-highlights-from-endo-2013-the-95th-annual-meeting-of-the-endocrine-society/6823/Diabetes Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. In this program, you will hear from global thought leadersIron Sequestration in Microbiota Biofilms in Treatment for IBD
https://reachmd.com/programs/Audioabstracts/iron-sequestration-in-microbiota-biofilms-in-treatment-for-ibd/10712/This integrative study provides deeper understanding of the interactivity between microbiota and anti-inflammatory drugs currently used to treat IBD.Immunotherapy for Management of Refractory and Super-Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/immunotherapy-for-management-of-refractory-and-super-refractory-status-epilepticus/39948/This review explores the role of neuroinflammation in refractory and super-refractory status epilepticus, as well as the role of therapeutic immunomodulation in their management.KOL KNOCKOUTTM CATARACT EDITION Beyond BCVA: Ensuring Patient Satisfaction in Refractive Outcomes
https://evolvemeded.com/specialty/cataract-refractive/kol-knockout-beyond-bcva-ensuring-patient-satisfaction-in-refractive-outcomes/32322/Content Source This continuing medical education (CME) activity captures content from three symposia. Activity Description This supplement summarizes a discussion on the recent advances that have improved outcomes and efficiencies in refractive cataract surgery. Target Audience This certified CMETailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
https://reachmd.com/programs/cme/tailoring-first-line-regimens-patient-centric-selection-in-metastatic-escc/33030/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
https://reachmd.com/programs/cme/ici-combination-regimens-for-first-line-treatment-of-metastatic-escc/33028/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
https://reachmd.com/programs/cme/the-impact-of-first-line-treatment-on-subsequent-treatment-options-for-metastatic-escc/33031/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.